Chen Zhe, Yang Yu, Han Ying, Wang Xijun
National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, Metabolomics Laboratory, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin, China.
Front Pharmacol. 2022 Jul 18;13:937333. doi: 10.3389/fphar.2022.937333. eCollection 2022.
Senegenin is the main bioactive ingredient isolated from the dried roots of Willd. In recent years, senegenin has been proved to possess a variety of pharmacological activities, such as anti-oxidation, anti-inflammation, anti-apoptosis, enhancement of cognitive function. Besides, it has a good development prospect for the treatment of neurodegenerative diseases, depression, osteoporosis, cognitive dysfunction, ischemia-reperfusion injury and other diseases. However, there is no systematic literature that fully demonstrates the pharmacological effects of senegenin. In order to meet the needs of new drug research and precise medication, this review summarized the neuroprotective effects, mechanisms and gastrointestinal toxicity of senegenin based on the literatures published from the past 2 decades. In addition, an in-depth analysis of the existing problems in the current research as well as the future research directions have been conducted in order to provide a basis for the clinical application of this important plant extract.
远志皂苷元是从远志干燥根中分离得到的主要生物活性成分。近年来,远志皂苷元已被证明具有多种药理活性,如抗氧化、抗炎、抗凋亡、增强认知功能。此外,它在治疗神经退行性疾病、抑郁症、骨质疏松症、认知功能障碍、缺血再灌注损伤等疾病方面具有良好的发展前景。然而,目前尚无系统的文献充分证明远志皂苷元的药理作用。为满足新药研发和精准用药的需求,本综述基于过去20年发表的文献,总结了远志皂苷元的神经保护作用、机制及胃肠道毒性。此外,还对当前研究中存在的问题以及未来的研究方向进行了深入分析,以便为这种重要植物提取物的临床应用提供依据。